TET2 and B-cell chronic lymphocytic leukemia: We also note that loss of 13q, a common alteration in CLL, co-occurred with CHIP mutations in TET2 and CBL, which may explain how CHIP mutations, despite leading to a myeloid bias, may also predispose individuals to lymphoid malignancy through co-occurring mutations.